1. Home
  2. VERU vs IVAC Comparison

VERU vs IVAC Comparison

Compare VERU & IVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • IVAC
  • Stock Information
  • Founded
  • VERU 1971
  • IVAC 1990
  • Country
  • VERU United States
  • IVAC United States
  • Employees
  • VERU N/A
  • IVAC N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • IVAC Industrial Machinery/Components
  • Sector
  • VERU Health Care
  • IVAC Technology
  • Exchange
  • VERU Nasdaq
  • IVAC Nasdaq
  • Market Cap
  • VERU 108.8M
  • IVAC 94.7M
  • IPO Year
  • VERU 1990
  • IVAC 1995
  • Fundamental
  • Price
  • VERU $0.98
  • IVAC $3.49
  • Analyst Decision
  • VERU Strong Buy
  • IVAC Hold
  • Analyst Count
  • VERU 4
  • IVAC 1
  • Target Price
  • VERU $4.00
  • IVAC N/A
  • AVG Volume (30 Days)
  • VERU 2.2M
  • IVAC 65.3K
  • Earning Date
  • VERU 02-06-2025
  • IVAC 02-03-2025
  • Dividend Yield
  • VERU N/A
  • IVAC N/A
  • EPS Growth
  • VERU N/A
  • IVAC N/A
  • EPS
  • VERU N/A
  • IVAC N/A
  • Revenue
  • VERU $16,886,419.00
  • IVAC $65,569,000.00
  • Revenue This Year
  • VERU N/A
  • IVAC $21.36
  • Revenue Next Year
  • VERU N/A
  • IVAC N/A
  • P/E Ratio
  • VERU N/A
  • IVAC N/A
  • Revenue Growth
  • VERU 3.62
  • IVAC 28.52
  • 52 Week Low
  • VERU $0.36
  • IVAC $2.46
  • 52 Week High
  • VERU $1.92
  • IVAC $4.51
  • Technical
  • Relative Strength Index (RSI)
  • VERU 74.65
  • IVAC 57.86
  • Support Level
  • VERU $0.70
  • IVAC $3.41
  • Resistance Level
  • VERU $0.81
  • IVAC $3.55
  • Average True Range (ATR)
  • VERU 0.11
  • IVAC 0.11
  • MACD
  • VERU 0.02
  • IVAC -0.01
  • Stochastic Oscillator
  • VERU 95.26
  • IVAC 50.00

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About IVAC Intevac Inc.

Intevac Inc designs and develops high-productivity, thin-film processing systems. The company's production platforms are designed for high-volume manufacturing of substrates with precise thin-film properties, such as the hard disk drive, display cover panel. The Thin Film Equipment segment also previously designed, developed, and marketed manufacturing equipment for the photovoltaic solar cell and semiconductor packaging industries. Geographically, the majority of revenue is generated from Asia.

Share on Social Networks: